{"id":"W4323532429","doi":"10.1182/bloodadvances.2022008414","title":"Dabrafenib, alone or in combination with trametinib, in <i>BRAF</i> V600–mutated pediatric Langerhans cell histiocytosis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; National Cancer Institute; National Institute for Health and Care Research; National Institutes of Health; Novartis Pharmaceuticals Corporation","keywords":"Trametinib; Dabrafenib; Medicine; Combination therapy; MEK inhibitor; Internal medicine; Adverse effect; Vomiting; Tolerability; Oncology; Langerhans cell histiocytosis; Gastroenterology; Vemurafenib; MAPK/ERK pathway; Cancer; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006806893,0.0003549123,0.0009852683,0.0002090905,0.0001600326,0.0003533399,0.0002763204,0.0002799146,0.0007417271],"category_scores_gemma":[0.0003843337,0.0001828165,0.0005403787,0.0003159419,0.0002288411,0.0002323454,0.0001523927,0.0007403652,0.000202434],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005390435,"about_ca_system_score_gemma":0.000451534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008554726,"about_ca_topic_score_gemma":0.004161064,"domain_scores_codex":[0.9996487,0.0001655464,0.00004513743,0.00004220287,0.00004537402,0.00005296112],"domain_scores_gemma":[0.9998204,0.00005195732,0.00005579642,0.0000127605,0.00001485295,0.00004417777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1179651,0.007388424,0.08985686,0.00289807,0.003396128,0.002867389,0.0004639726,0.004276879,0.1738296,0.0004748946,0.006616442,0.5899662],"study_design_scores_gemma":[0.1034236,0.3411059,0.3094888,0.000567158,0.004520312,0.0216925,0.0005560074,0.005820662,0.1501664,0.0005232689,0.06200232,0.0001332355],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9826521,0.0140986,0.0006608185,0.0002055771,0.00004737351,0.0002148168,0.0003727132,0.00004474975,0.001703332],"genre_scores_gemma":[0.9947015,0.003910169,0.0004942322,0.00009379522,0.00002490225,0.00007906858,0.0003766919,0.000006124108,0.0003135621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009852683,"threshold_uncertainty_score":0.003911078,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01175182767218733,"score_gpt":0.2581150176213485,"score_spread":0.2463631899491612,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}